Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
09/1999
09/21/1999US5955610 Antiviral compounds
09/21/1999US5955600 Method for the synthesis of nucleotide or oligonucleotide phosphoramidites
09/21/1999US5955599 Condensing in presence of 1h-tetrazole, a methoxy-3'-o (phosphoramidite) 5'-o-(4,4'-dimethoxytriphenyl) methyl nucleoside with another nucleoside; removing protective group without demethylating linkages
09/21/1999US5955591 Phosphotriester oligonucleotides, amidites and method of preparation
09/21/1999US5955589 Gapped 2' modified oligonucleotides
09/21/1999US5955447 Administering as anticoagulant; treating cardiovascular disorders
09/21/1999US5955446 Viricides for herpes infections
09/21/1999US5955285 Method of identifying individuals at risk of suffering from cerebral amyloidosis
09/17/1999CA2266089A1 Methods for producing nucleoside derivatives and intermediates therefor
09/16/1999WO1999045935A1 Novel nucleoside analogs and uses in treating disease
09/16/1999WO1999024452A3 Pyrimidine derivatives for labeled binding partners
09/16/1999WO1998041531A3 Solvent for biopolymer synthesis, solvent microdroplets and methods of use
09/16/1999CA2322494A1 Novel nucleoside analogs and uses in treating disease
09/15/1999EP0942000A2 2'Modified oligonucleotides
09/15/1999EP0941370A2 Stabilized aqueous nucleoside triphosphate solution
09/15/1999EP0941314A1 Target nucleic acid sequence amplification method
09/15/1999EP0941099A1 Method of treating bronchitis with uridine triphosphates and related compounds
09/15/1999CN1228785A Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same
09/15/1999CN1228770A Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
09/15/1999CN1228704A Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
09/14/1999US5952500 Nucleoside derivatives
09/14/1999US5952499 Therapeutic compound-fatty acid conjugates
09/14/1999US5952478 Nucleotides and analogs in which both the 3' oxy linkage and the 5' oxy linkage are replaced by carbon linkages; for antisense agents; viricides against influenza, herpes and human immune deficiency virus; anticarcinogenic agents
09/14/1999US5952312 NADH and NADPH therapeutic agents for nasal, sublingual, rectal and dermal administration
09/14/1999CA2170869C Amine-derivatized nucleosides and oligonucleosides
09/14/1999CA2130664C Antiparasitic agents
09/14/1999CA2118491C Avermectin difluoro derivatives
09/13/1999CA2232074A1 Granulatimide compounds as g2 checkpoint inhibitors
09/10/1999WO1999045016A2 Novel prodrugs for phosphorus-containing compounds
09/10/1999WO1999044646A1 Novel imaging agents and methods for the preparation and use thereof
09/10/1999WO1999029710A3 Purification method for producing fludarabin phosphate
09/08/1999EP0939637A1 Method of treating sinusitis with uridine triphosphates and related compounds
09/08/1999EP0510085B1 Dna-dependent rna polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays
09/07/1999US5948903 Nucleosides incorporated into oligonucleotides for antisense agents; compounds have unique steric properties, have better cellular transport properties and are adapted for placement into the minor groove of hybrid structure
09/07/1999US5948648 Base portion, rigid linker, spacer, and linkage pair or label; for use as chain extenders or chain terminators in sanger sequencing reactions or polymerase chain reactions
09/07/1999US5948624 Methods for the detection and isolation of biomolecules
09/07/1999CA2028416C Anhydrous crystal of 4-carbamoyl-1-.beta.-d-ribofuranosyl imidazolium-5-oleate
09/02/1999WO1999043691A1 2'-fluoronucleosides
09/02/1999WO1999043690A1 L-4'-arabinofuranonucleoside compound and medicine composition comprising the same
09/02/1999WO1999043313A1 Compounds and methods for use in treating neoplasia, cancer, hyperproliferative cell growth and chronic inflammatory diseases
09/02/1999WO1999029702A3 METHOD FOR SYNTHESIZING 9-(2,3-DIDEOXY-2-FLUORO-β-D-THREO-PENTOFURANOSYL)ADENINE (β-FddA)
09/02/1999CA2321715A1 Compounds and methods for use in treating neoplasia, cancer, hyperproliferative cell growth and chronic inflammatory diseases
09/01/1999EP0938322A2 Use of uridine triphosphates and related compounds for the prevention and treatment of pneumonia in immobilized patients
09/01/1999CN1227491A Method for treating sinusitis with uridine triphosphates and related compounds
09/01/1999CN1044911C Method for preparing prodrug
08/1999
08/31/1999US5945547 Imtermediate in process to make 2', 2'-difluoronucleosides
08/31/1999US5945527 Reacting cytosine containing a leaving group attached to 5- or 6-postion of molecule, isolating modified nucleoside; for novel fungicides, viricides, bactericides, antitumor agents
08/31/1999US5945524 Nucleoside with dansylethoxycarbonyl group as base-labile 5'-hydroxyl protective group; for efficient synthesis
08/31/1999US5945521 Preparation of phosphorothioate oligomers
08/31/1999US5945406 Anticancer agents; treatment for metastatic liver cancer, fungal infections, psoriasis; used in manufacture of drugsto prevent cell division
08/26/1999WO1999042617A1 Levo-monosaccharide in a nucleoside analog for use as an antiretroviral agent
08/26/1999CA2320743A1 Levo-monosaccharide in a nucleoside analog for use as an antiretroviral agent
08/24/1999US5942497 Purine compound and catecholamine compound containing compositions and methods for administration
08/19/1999WO1999041275A1 Prodrugs
08/19/1999WO1999041268A1 Nucleosides
08/19/1999WO1999041267A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives
08/19/1999WO1999040916A1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
08/19/1999WO1999024451A3 Adenosine a1 receptor agonists
08/19/1999WO1999024450A3 Adensine a1 receptor agonists
08/19/1999WO1999024449A3 Adenosine a1 receptor agonists
08/19/1999CA2319009A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives
08/19/1999CA2318978A1 Prodrugs
08/19/1999CA2318975A1 Prodrugs of 2'3'-dideoxy-3'-fluoro guanosine
08/18/1999EP0935466A1 Method and composition for inhibiting cellular irreversible changes due to stress
08/18/1999CN1226169A Use of uridine triphosphates and related compounds for prevention and treatment of pneumonia in immobilized patients
08/17/1999US5939555 Polymorphs B and C of 1- 2,4-dichloro-β- (7-chlorobenzo b!thien-3-yl)methoxy!phenethyl!imidazole mononitrate
08/17/1999US5939543 Stable solid 2-octynyl adenosine and process for producing the same
08/17/1999US5939402 Treating plasmodium, viral infections or parasites in mammals
08/17/1999US5939290 Modified sialyl Lewisx compounds
08/12/1999WO1999040223A1 Dideoxy dye terminators
08/12/1999WO1999040099A1 5'-deoxycytidine derivatives
08/12/1999WO1999024452A9 Pyrimidine derivatives for labeled binding partners
08/11/1999EP0934330A1 Base-protected nucleotide analogs with protected thiol groups
08/11/1999EP0934325A1 Tetraphosphonate bicyclic trisanhydrides
08/11/1999EP0789706A4 Sugar modified nucleosides and their use for synthesis of oligonucleotides
08/10/1999US5936087 Dibenzorhodamine dyes
08/10/1999US5936080 Compositions and methods for the synthesis of organophosphorus derivatives
08/10/1999US5936077 Solid phase synthesis of oligonucleotides
08/10/1999US5935555 Pharmaceutical formulations for treating cystic fibrosis
08/10/1999CA2004695C Phospholipid nucleosides
08/05/1999WO1999038879A1 Process for producing nucleoside derivatives
08/05/1999WO1999038878A1 Novel synthons for oligonucleotide synthesis
08/05/1999WO1999038877A2 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
08/05/1999WO1999015542A3 Linker nucleoside, and production and use of the same
08/05/1999WO1999014226A3 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
08/05/1999WO1995031429A8 Photocleavable agents and conjugates for the detection and isolation of biomolecules
08/05/1999CA2318748A1 Novel synthons for oligonucleotide synthesis
08/05/1999CA2318278A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
08/05/1999CA2318277A1 Process for producing nucleoside derivatives
08/03/1999US5932719 Process to prepare pyrimidine nucleosides
07/1999
07/29/1999WO1999037810A1 A method, reagent solution and kits for dna sequencing
07/29/1999WO1999037753A1 Enzyme catalyzed therapeutic agents
07/29/1999WO1999037717A1 Asymmetric cyanine dye quenchers
07/29/1999WO1999037151A1 Method and compositions for promotion of wound healing
07/29/1999WO1999012951A9 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
07/29/1999CA2325002A1 Method and compositions for promotion of wound healing
07/28/1999EP0931038A1 Novel substance library and supramolecular complexes produced therewith
07/27/1999US5929046 Pyrimidine and purine derivatives and their use in treating tumour cells
07/27/1999US5928919 Mutant family b enzymes with reduced or non 3' to 5' exonuclease activity; for high quality (sanger) chain stopping sequencing reactions
07/27/1999US5928862 Competitive homogeneous assay